FIELD LOG / QUESTIONS
Semax FAQ
Direct answers, drawn from the published record and clearly separated from community reports. Quantitative answers are cited.
Does Semax help with focus and mood?
In animal and in-vitro work, the building blocks are there: intranasal Semax raised BDNF protein in rat basal forebrain at 3 hours [1], and in human serum it inhibited enkephalin-degrading enzymes that affect mood-related opioid signaling [3]. Human focus-and-mood data is scarce. The research-use community very commonly reports clarity, focus, and a modest mood lift — anecdotal, not clinical evidence.
Is Semax effective as a nootropic for cognition?
Preclinically, yes in the sense that it regulates the neurotrophins BDNF and NGF tied to learning and memory [1][2] and prevented memory inhibition in a rodent toxicity model [10]. But there are no published Western controlled trials in healthy people, so "effective as a nootropic" is not established in humans. The cognition case rests on rodent mechanism plus anecdotal user reports.
How does Semax increase BDNF?
Semax raises BDNF rapidly and region-specifically. In rats it increased BDNF protein in basal forebrain at 3 hours and bound a specific, reversible, calcium-dependent site with a dissociation constant of 2.4 nM [1], and it regulated BDNF together with its TrkB receptor in the hippocampus [9]. A single 50 microg/kg intranasal dose also shifted BDNF and NGF mRNA across brain regions [2].
Has anyone found Semax effective for studying or exams?
Many in the research-use community report sustained focus and easier reading comprehension that they find useful for demanding work, with memory gains said to be clearest after several consecutive days [reported, anecdotal]. That maps onto the rodent neurotrophin findings [1][2] but is not the same as controlled human cognition data, which does not exist here. Treat exam claims as anecdotal.
What is Semax?
Semax is a synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, built from the ACTH(4-7) hormone fragment with a Pro-Gly-Pro tail added for stability. It lacks ACTH's cortisol-releasing action. It is studied as a nootropic and neuroprotective peptide [1][4], is a prescription drug in Russia and Ukraine, and is an unscheduled research chemical elsewhere, including the US.
What is Semax peptide used for?
In Russia and Ukraine it is a registered prescription drug for ischemic stroke, transient ischemic attack, cognitive impairment, and optic-nerve disease [14]. Everywhere else it is a research chemical studied — mostly in rodents — for cognition and for neuroprotection in stroke models [4]. There are no FDA- or EMA-approved uses and no Western controlled trials.
Is Semax a peptide?
Yes. Semax is a peptide — specifically a heptapeptide, a chain of seven amino acids (Met-Glu-His-Phe-Pro-Gly-Pro), with a molecular weight of 813.9 Da. It is a synthetic analog of a fragment of the hormone ACTH, engineered with a Pro-Gly-Pro tail to resist enzymatic breakdown [6].
How does Semax work?
Its best-supported action is neurotrophic: it rapidly and region-specifically raises BDNF and NGF in the rodent brain [1][2]. It also inhibits enkephalin-degrading enzymes in human serum (IC50 ~10 microM) [3] and, in ischemia, shifts immune and vascular gene expression [5]. It is not a classical stimulant — it modulates rather than directly drives dopamine [8].
How does Semax modulate BDNF and NGF expression in research models?
Region-specifically and rapidly. A single 50 microg/kg intranasal dose in rats raised NGF and BDNF mRNA in hippocampus and BDNF in brainstem and cerebellum, while NGF mRNA fell in frontal cortex [2]. At the protein level, BDNF rose in basal forebrain at 3 hours via a specific 2.4 nM binding site [1]. The direction of change depends on the region.
Is Semax a neuroprotective peptide for stroke research?
Yes, that is its deepest preclinical record. In a rat model of focal prefrontal-cortex ischemia, 6 days of intranasal Semax reduced cortical infarct volume and preserved memory [4], and genome-wide analysis after middle-cerebral-artery occlusion linked its protection to immune and vascular gene shifts [5]. This underlies its registered Russian stroke indication; Western controlled trials are lacking.
What are the neuroprotective properties of the ACTH fragment peptide Semax in ischemia-reperfusion models?
In ischemia models Semax reduced cortical infarct volume and protected memory after focal photoinduced ischemia [4]. Mechanistically, its neuroprotection appears driven by immunomodulation and vascular-gene regulation — over half the genes it affected after middle-cerebral-artery occlusion were immune-related [5] — rather than a single receptor action. Cell-level work showed protection against oxidative-stress death [12].
What does Semax do in animal models of neurodegeneration?
It tends to preserve function and reduce pathology. In a 2025 Alzheimer's animal model, Semax and a derivative improved cognition and reduced cortical and hippocampal amyloid inclusions [16]; in ischemia it cut infarct volume and protected memory [4]; and it prevented heavy-metal-induced learning and memory inhibition [10]. All of this is preclinical — no controlled human neurodegeneration trials exist.
Does Semax have anti-depressive effects?
There is a plausible mechanism and animal support, but no Western clinical proof. Semax inhibits enkephalin-degrading enzymes in human serum (IC50 ~10 microM), which would prolong mood-related opioid signaling [3], and it modulates serotonergic turnover in mice [8]. The research-use community commonly reports a modest mood lift — anecdotal, not clinical evidence, and far from universal.
Is Semax useful for anxiety?
Anxiety is more Selank's studied territory than Semax's. One of the few human-imaging studies looked at Selank and Semax together using resting-state functional connectivity [11], but Semax's published record centers on cognition and neuroprotection, not anxiety. Some users report a calmer, more even-keeled feeling — anecdotal — while others report irritability instead.
I fall asleep on Semax - does Semax make you tired?
It can, for some people. Semax is not a classical stimulant — human-imaging work studied it via functional connectivity rather than as a wake-promoting drug [11] — so a non-stimulant profile is consistent with the minority who report drowsiness or an afternoon dip rather than activation. Reports of tiredness or falling asleep are anecdotal and are not universal; most do not report sedation.
Ashwagandha, L-theanine, or Semax for anxiety - which matters most?
The literature here cannot rank them — Semax's published record centers on cognition and neuroprotection, not anxiety, and the human evidence is a single connectomic imaging study [11]. Ashwagandha and L-theanine are outside this site's scope. For anxiety specifically there is no controlled comparison that places Semax against them, so any ranking would be anecdotal, not evidence-based.
What effects does Semax have on dopamine and serotonin pathways?
Nuanced ones. In C57BL mice, Semax at 0.15 mg/kg raised the serotonin metabolite 5-HIAA (tissue +25% at 2 hours) but did not by itself change baseline dopamine; given before amphetamine it markedly potentiated amphetamine-evoked dopamine release [8]. So it modulates serotonergic turnover and amplifies dopamine signaling rather than directly raising baseline dopamine.
Is Semax a stimulant?
No, not in the classical sense. In mice Semax did not raise baseline dopamine on its own; it potentiated amphetamine-evoked dopamine and modulated serotonin turnover [8]. The community description of "clarity without jitters" fits a non-stimulant profile, which is also why some users report sleepiness rather than activation. It is studied as a nootropic, not a psychostimulant.
What is the difference between Semax and Selank?
They are distinct peptides with different origins and aims. Semax is built from an ACTH hormone fragment and is studied mainly for cognition and neuroprotection; Selank is built from the immune peptide tuftsin and is studied mainly as an anxiolytic. They overlap in enzyme-inhibition assays (Semax IC50 ~10 microM vs Selank ~20 microM) [3] but are not interchangeable. See Semax vs Selank.
How does Semax compare to Selank for cognitive effects and anxiety?
Roughly: Semax leans cognitive and neuroprotective, Selank leans anxiolytic. Semax's record centers on BDNF/NGF induction [1][2] and ischemia neuroprotection [4]; Selank's reputation rests on anxiety endpoints outside this site's scope. The two were studied together in one human connectomic imaging study [11], but most evidence is rodent and in-vitro, so confident head-to-head claims are not warranted.
Can Semax be useful for Parkinson's disease neuroprotection?
Only preclinically, and the direct Parkinson's evidence is thin. Semax's documented neuroprotection is in ischemia models [4][5], and there are no controlled human trials for Parkinson's disease. Related work shows it can act on opioid-receptor gene regulation and improve functional recovery in a mouse spinal-cord-injury model [7], but extending that to Parkinson's in people is not supported by published trials.
Does Semax affect dopaminergic neurons in Parkinson's models?
The dopaminergic data is mostly from healthy-animal pharmacology, not Parkinson's models: Semax modulated serotonin turnover and potentiated amphetamine-evoked dopamine release without raising baseline dopamine in mice [8]. Parkinson's-specific protection of dopaminergic neurons is not established in controlled human studies, and Semax's strongest neuroprotection record is in ischemia rather than Parkinson's [4].